Abstract: Rheumatoid arthritis (RA) is a complex disease including autoimmune disorder and resulting in inflammation. It also shows progressive proliferation of synoviocytes, and these synoviocytes destroys articular structure. In order to understand the mechanism of this abnormal proliferation of RA-originated synoviocytes in molecular level, we analyzed the gene expression profiles by using DNA chips that contain more than 10,000 genes. Comparing the expression profiles of normal and RA-originated synoviocytes, we found several genes that are highly expressed in RA-originated synoviocytes than normal synoviocytes. Among these genes, we focused on one hypothetical protein, cDNA of which contains one reading frame in its DNA fragment, indicating that this fragment is a part of large mRNA structure. The expression of this gene in RA-originated synoviocytes is about three times higher than that in normal synoviocytes by DNA chip analysis. After cDNA cloning of this mRNA, we found that the gene is identical with lumican, which encodes a collagen binding, extracellular matrix protein. This mRNA was widely distributed in many tissues but its alternatively spliced forms are differently expressed in various tissues.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes the immune system to attack the joints, arising inflammation and destruction of the joints. These joints are characterized by inflamed synovial hyperplasia with excessive inflammatory cell infiltration, leading to erosion of articular cartilage and marginal bone, with subsequent joint destruction.
Much information over the past two decades contributed to the better understanding of the mechanism of inflammation.
Nevertheless, the pathogenesis of synovitis has not been fully elucidated 1) . In RA joints, synovial cells show abnormal growth, and these synoviocytes cover the articular structure destroying articular cartilage. Also the mechanism of these phenomena is not fully understood in molecular level. Recently, some cytokines, receptors and transcription factors were shown to contribute to development of this disease [2] [3] [4] [5] [6] . It was also shown that some genetical background e.g. SNPs associate to the generation of this disease 7) . We have also shown that increased expression of WISP genes might promote the abnormal proliferation of synoviocytes in RA 8) .
DNA chip technology 9) made analysis of the expression of thousands genes possible at one time. This technology reveals the difference of gene expression between different types of cells or cells in different conditions. In addition, this technology contributes to the isolation of tumor-specific mutation in chromosome (CGH) or detection of genetic polymorphisms (SNPs) 10) . As a result, this technology has provided novel diagnostic methods and therapeutic target for developing medicine.
Lumican is a small leucine-rich proteoglycan which belongs to the family including decorin, biglycan, fibromodulin, keratocan, epiphycan and osteoglycin. Lumican is highly expressed in corneal stroma as the major keratan sulfate proteoglycan. It is also expressed in other extracellular matrices (ECM), such as skin, muscle, and cartilage [11] [12] [13] [14] [15] [16] . The results of gene knockout studies showed that lumican plays an important role in the formation of structural phenotype of the mature collagen in various tissues.
Another member of the small leucine-rich proteoglycan family, decorin showed the same function as lumican, because decorindeficient mice were very similar to those of lumican-deficient mice 17, 18) . Lumican also showed suppressive effect on colony formation in soft agar or tumor growth of rat fibroblast F204 cells transformed by K-ras or v-src oncogene 19) .
In this study, we compared the expression levels of about ten thousand of genes between synovial cells from RA and normal control by using DNA chip, and identified the three novel genes or uncharacterized genes which were up-regulated in RA-originated synoviocytes. Furthermore, we analyzed the expression and structure of lumican, one of these three genes, and also investigated the relationship of this protein with other proteins. 
Materials and Methods

Isolation and culture of synovial cells
DNA chip analysis
High-density DNA chip (Toyobo Co. Ltd., Tokyo, Japan) containing over 10,000 known and unknown human genes were used for hybridization studies. Hybridization was performed following the instructions of manufacturer's protocol. The chips were aligned on an Imaging scanner (Applied Biosystems Inc, CA) and saved as digital images.
Reverse transcriptase-PCR
Total RNA from normal or RA-originated synoviocytes was reverse transcribed to cDNA using oligo dT 16 primers with AMVderived reverse transcriptase, and the resulted first-strand cDNA was amplified with each RASP (RA specific cDNA) specific primer set. The amplification condition was as follows: 95°C (1 min) -57°C (1 min) -72°C (2 min) for 35 cycles. The PCR products were applied on agarose gels (2 %) and electrophoresed. 
Northernblot analysis
Structural analysis
Physico-chemical profiles of RASP were analyzed by using web platforms. For example, AAs sequence of RASP10 (1040 bp, 131AAs) was aligned in some square of analysis page of web analysis platform. Then the sequence was transmitted to the host computer site, and the results were soon retrieved from this host computer. The same operation was performed by using different programs on web platforms.
Results
DNA chip analysis
We utilized DNA chip technology to compare multiple gene expression profiles, representative of human adult normal (leg sarcoma) synoviocytes (n=5 individuals) and RA-originated synoviocytes (n=5 individuals). Total RNA was isolated from primary cultures of OA or RA synoviocytes and then hybridized to high density DNA chip including over 10,000 human genes. (Table 1) . Among these genes, three unknown genes (EST clones) were highly expressed in RA-originated synoviocytes over two-folds. We focused on these cDNAs (RASP2, RASP3 and RASP10).
RT-PCR analysis of novel or unknown genes
Among the several genes that were differentially expressed between normal and RA-originated synoviocytes on DNA chips, we selected three RASP genes. They belonged to the EST clones and were characterized as unknown genes (RASP3) or unknown proteins (RASP2 and RASP10) that encode their proteins (Fig.  2) . We also performed RT-PCR analysis of these cDNA clones to confirm their differential expression patterns between normal and RA-originated synoviocytes. When comparison of the expression of three RASP genes between normal and RA-originated synoviocytes was made, all three genes were highly expressed in RA-originated synoviocytes. (Fig. 2) as shown in the results of DAN chips. Among them, RASP2 and RASP10 showed high expression in RA-originated synoviocytes.
Structure analysis of RASP10
RASP10 cDNA (1040 bp) is included in human ovary tumor cDNA and encodes unknown protein with 131 AAs. We analyzed physico-chemical profiles of this hypothetical protein including secondary structure and hydrophobicity pattern by using some web-based platform for analysis of secondary structure of proteins.
The prediction results showed that this protein has highly characteristic structure (Fig. 3) . Based on predicted secondary structure and hydrophobicity, the N-terminal half of RASP10 was hydrophilic and C-terminal half of RASP10 was hydrophobic.
Furthermore, there were typical helix structures and several phosphorylation sites by PKC and TK, indicating that RASP10 is a kind of membrane protein which recognizes some unknown ligands.
Northern blot analysis of RASP2
Next, we analyzed the expression pattern of RASP2 mRNA.
RASP2 cDNA (1717 bp) is included in human ovary tumor cDNA and encodes a 338 AAs protein. This protein was found to be a keratin sulfate proteoglycan, named lumican. Lumican is a small highest expression in heart and skeletal muscle. Contrary, the normal mRNA was highly expressed in heart and placenta.
Discussion
In the present study, we compared representative gene expressed profiles between normal and RA samples, using high density DNA chips. This chip technology offers the advantage of comparing multiple profiles generated from different subjects, although it leucine-rich proteoglycan and is highly expressed in corneal stroma as the major keratan sulfate proteoglycan. It plays an important role in the formation of structural phenotype of the mature collagen in various tissues. Northern blot analysis of RASP2 mRNA in various tissues showed that there were two kinds of mRNA with different sizes (1.7kb normal mRNA and small mRNA), and these two RNAs were differentially distributed in various tissues (Fig.4) . The small mRNA (about 0.3kb) showed high expression in heart, skeletal muscle, adrenal gland, lymph In this study, we used high density DNA chips with over 10,000 human genes. We prepared fluorescent-labeled cDNA probes from total RNA isolated from synoviocytes of normal Further investigation for analysis of the function of these proteins in the process of abnormal growth of RA synoviocytes is warranted.
